Gillespie Syndrome - 11 Studies Found Completed : A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients : Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients : 2009-08-18 : Drug: Vehicle Placebo cream Completed : Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients : Basal Cell Nevus Syndrome : 2016-04-27 : Drug: patidegib patidegib gel Completed : To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) : Basal Cell Nevus Syndrome Gorlin Syndrome : 2009-08-05 : Drug: GDC-0449 capsule, 150 mg, one pill daily, 18 months Completed : Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas : Basal Cell Nevus Syndrome Gorlin's Syndrome : 2012-03-14 : Drug: Vismodegib 150 mg per da Completed : Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) : Basal Cell Carcinoma Gorlin Syndrome Drug: LDE225 supplied as 100 m Terminated : Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. : Basal Cell Carcinoma Nevoid Basal Cell Carcinoma Syndrome : 2002-11-15 : Drug: verteporfin PDT Active, not recruiting : Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome : Basal Cell Nevus Syndrome : 2014-06-02 : Drug: Levulan Levulan applicat Active, not recruiting : Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms : Musculoskeletal Complications : 2013-07-02 : Dietary Supplement: levocarnitine Completed : A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions : Basal Cell Carcinoma : 2009-11-16 Recruiting : Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas : Basal Cell Carcinomas : 2016-07-01 : Drug: patidegib gel 2% - cohort 1 Next >>>